nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—hematologic cancer	0.459	1	CbGaD
Cefotetan—ALB—Imatinib—hematologic cancer	0.0859	0.383	CbGbCtD
Cefotetan—ALB—Prednisone—hematologic cancer	0.0566	0.252	CbGbCtD
Cefotetan—ALB—Irinotecan—hematologic cancer	0.0537	0.239	CbGbCtD
Cefotetan—ALB—Methotrexate—hematologic cancer	0.0284	0.126	CbGbCtD
Cefotetan—Cefazolin—PON1—hematologic cancer	0.00161	0.488	CrCbGaD
Cefotetan—Cefpiramide—ALB—hematologic cancer	0.000426	0.129	CrCbGaD
Cefotetan—Cefonicid—ALB—hematologic cancer	0.000371	0.112	CrCbGaD
Cefotetan—Cefmetazole—ALB—hematologic cancer	0.000326	0.0988	CrCbGaD
Cefotetan—Cefoperazone—ALB—hematologic cancer	0.000218	0.0661	CrCbGaD
Cefotetan—Cefazolin—ALB—hematologic cancer	0.00018	0.0543	CrCbGaD
Cefotetan—Ceftriaxone—ALB—hematologic cancer	0.00017	0.0515	CrCbGaD
Cefotetan—Body temperature increased—Carmustine—hematologic cancer	0.000162	0.000533	CcSEcCtD
Cefotetan—Dermatitis—Lenalidomide—hematologic cancer	0.000162	0.000533	CcSEcCtD
Cefotetan—Diarrhoea—Bortezomib—hematologic cancer	0.000162	0.000533	CcSEcCtD
Cefotetan—Urticaria—Alitretinoin—hematologic cancer	0.000161	0.000531	CcSEcCtD
Cefotetan—Vomiting—Hydroxyurea—hematologic cancer	0.000161	0.000531	CcSEcCtD
Cefotetan—Discomfort—Prednisolone—hematologic cancer	0.000161	0.00053	CcSEcCtD
Cefotetan—Haemoglobin—Prednisone—hematologic cancer	0.000161	0.000529	CcSEcCtD
Cefotetan—Abdominal pain—Alitretinoin—hematologic cancer	0.000161	0.000528	CcSEcCtD
Cefotetan—Body temperature increased—Alitretinoin—hematologic cancer	0.000161	0.000528	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vincristine—hematologic cancer	0.00016	0.000527	CcSEcCtD
Cefotetan—Haemorrhage—Prednisone—hematologic cancer	0.00016	0.000526	CcSEcCtD
Cefotetan—Rash—Hydroxyurea—hematologic cancer	0.00016	0.000526	CcSEcCtD
Cefotetan—Dermatitis—Hydroxyurea—hematologic cancer	0.00016	0.000526	CcSEcCtD
Cefotetan—Urticaria—Ifosfamide—hematologic cancer	0.00016	0.000525	CcSEcCtD
Cefotetan—Body temperature increased—Ifosfamide—hematologic cancer	0.000159	0.000522	CcSEcCtD
Cefotetan—Abdominal pain—Ifosfamide—hematologic cancer	0.000159	0.000522	CcSEcCtD
Cefotetan—Pancytopenia—Methotrexate—hematologic cancer	0.000159	0.000522	CcSEcCtD
Cefotetan—Anaphylactic shock—Etoposide—hematologic cancer	0.000159	0.000522	CcSEcCtD
Cefotetan—Diarrhoea—Vinorelbine—hematologic cancer	0.000158	0.00052	CcSEcCtD
Cefotetan—Hypersensitivity—Thalidomide—hematologic cancer	0.000157	0.000517	CcSEcCtD
Cefotetan—Nausea—Melphalan—hematologic cancer	0.000157	0.000517	CcSEcCtD
Cefotetan—Anaphylactic shock—Prednisolone—hematologic cancer	0.000156	0.000515	CcSEcCtD
Cefotetan—Neutropenia—Methotrexate—hematologic cancer	0.000156	0.000514	CcSEcCtD
Cefotetan—Pruritus—Thiotepa—hematologic cancer	0.000156	0.000514	CcSEcCtD
Cefotetan—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000156	0.000513	CcSEcCtD
Cefotetan—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000156	0.000513	CcSEcCtD
Cefotetan—Thrombocytopenia—Etoposide—hematologic cancer	0.000155	0.000511	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—hematologic cancer	0.000155	0.000509	CcSEcCtD
Cefotetan—Abdominal pain—Vincristine—hematologic cancer	0.000155	0.000509	CcSEcCtD
Cefotetan—Body temperature increased—Vincristine—hematologic cancer	0.000155	0.000509	CcSEcCtD
Cefotetan—Nausea—Lenalidomide—hematologic cancer	0.000153	0.000503	CcSEcCtD
Cefotetan—Convulsion—Triamcinolone—hematologic cancer	0.000153	0.000502	CcSEcCtD
Cefotetan—Urticaria—Mitoxantrone—hematologic cancer	0.000152	0.000498	CcSEcCtD
Cefotetan—Hypersensitivity—Carmustine—hematologic cancer	0.000151	0.000497	CcSEcCtD
Cefotetan—Pruritus—Thalidomide—hematologic cancer	0.000151	0.000497	CcSEcCtD
Cefotetan—Diarrhoea—Thiotepa—hematologic cancer	0.000151	0.000497	CcSEcCtD
Cefotetan—Body temperature increased—Irinotecan—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Abdominal pain—Mitoxantrone—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Body temperature increased—Mitoxantrone—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Abdominal pain—Irinotecan—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Nausea—Hydroxyurea—hematologic cancer	0.000151	0.000496	CcSEcCtD
Cefotetan—Vomiting—Bortezomib—hematologic cancer	0.000151	0.000495	CcSEcCtD
Cefotetan—Hypersensitivity—Alitretinoin—hematologic cancer	0.00015	0.000492	CcSEcCtD
Cefotetan—Vomiting—Bleomycin—hematologic cancer	0.000149	0.000491	CcSEcCtD
Cefotetan—Rash—Bortezomib—hematologic cancer	0.000149	0.000491	CcSEcCtD
Cefotetan—Dermatitis—Bortezomib—hematologic cancer	0.000149	0.000491	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—hematologic cancer	0.000149	0.000488	CcSEcCtD
Cefotetan—Discomfort—Triamcinolone—hematologic cancer	0.000148	0.000488	CcSEcCtD
Cefotetan—Rash—Bleomycin—hematologic cancer	0.000148	0.000487	CcSEcCtD
Cefotetan—Dermatitis—Bleomycin—hematologic cancer	0.000148	0.000487	CcSEcCtD
Cefotetan—Hypersensitivity—Ifosfamide—hematologic cancer	0.000148	0.000487	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	0.000148	0.000486	CcSEcCtD
Cefotetan—Vomiting—Vinorelbine—hematologic cancer	0.000147	0.000483	CcSEcCtD
Cefotetan—Body temperature increased—Gemcitabine—hematologic cancer	0.000147	0.000483	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—hematologic cancer	0.000146	0.000481	CcSEcCtD
Cefotetan—Diarrhoea—Thalidomide—hematologic cancer	0.000146	0.000481	CcSEcCtD
Cefotetan—Rash—Vinorelbine—hematologic cancer	0.000146	0.000479	CcSEcCtD
Cefotetan—Dermatitis—Vinorelbine—hematologic cancer	0.000146	0.000479	CcSEcCtD
Cefotetan—Hypersensitivity—Vincristine—hematologic cancer	0.000144	0.000474	CcSEcCtD
Cefotetan—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000144	0.000473	CcSEcCtD
Cefotetan—Pruritus—Alitretinoin—hematologic cancer	0.000144	0.000473	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—hematologic cancer	0.000143	0.000471	CcSEcCtD
Cefotetan—Pruritus—Ifosfamide—hematologic cancer	0.000142	0.000467	CcSEcCtD
Cefotetan—Nausea—Bortezomib—hematologic cancer	0.000141	0.000463	CcSEcCtD
Cefotetan—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000141	0.000462	CcSEcCtD
Cefotetan—Hypersensitivity—Irinotecan—hematologic cancer	0.000141	0.000462	CcSEcCtD
Cefotetan—Vomiting—Thiotepa—hematologic cancer	0.00014	0.000462	CcSEcCtD
Cefotetan—Diarrhoea—Carmustine—hematologic cancer	0.00014	0.000462	CcSEcCtD
Cefotetan—Nausea—Bleomycin—hematologic cancer	0.00014	0.000459	CcSEcCtD
Cefotetan—Rash—Thiotepa—hematologic cancer	0.000139	0.000458	CcSEcCtD
Cefotetan—Dermatitis—Thiotepa—hematologic cancer	0.000139	0.000457	CcSEcCtD
Cefotetan—Diarrhoea—Alitretinoin—hematologic cancer	0.000139	0.000457	CcSEcCtD
Cefotetan—Agranulocytosis—Methotrexate—hematologic cancer	0.000139	0.000457	CcSEcCtD
Cefotetan—Convulsion—Dexamethasone—hematologic cancer	0.000139	0.000456	CcSEcCtD
Cefotetan—Convulsion—Betamethasone—hematologic cancer	0.000139	0.000456	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000138	0.000455	CcSEcCtD
Cefotetan—Diarrhoea—Ifosfamide—hematologic cancer	0.000137	0.000452	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—hematologic cancer	0.000137	0.000452	CcSEcCtD
Cefotetan—Nausea—Vinorelbine—hematologic cancer	0.000137	0.000452	CcSEcCtD
Cefotetan—Body temperature increased—Cisplatin—hematologic cancer	0.000137	0.00045	CcSEcCtD
Cefotetan—Vomiting—Thalidomide—hematologic cancer	0.000136	0.000447	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—hematologic cancer	0.000135	0.000445	CcSEcCtD
Cefotetan—Rash—Thalidomide—hematologic cancer	0.000135	0.000443	CcSEcCtD
Cefotetan—Discomfort—Dexamethasone—hematologic cancer	0.000135	0.000442	CcSEcCtD
Cefotetan—Discomfort—Betamethasone—hematologic cancer	0.000135	0.000442	CcSEcCtD
Cefotetan—Dermatitis—Thalidomide—hematologic cancer	0.000135	0.000442	CcSEcCtD
Cefotetan—Haemoglobin—Methotrexate—hematologic cancer	0.000134	0.000442	CcSEcCtD
Cefotetan—Diarrhoea—Vincristine—hematologic cancer	0.000134	0.000441	CcSEcCtD
Cefotetan—Haemorrhage—Methotrexate—hematologic cancer	0.000134	0.00044	CcSEcCtD
Cefotetan—Pruritus—Gemcitabine—hematologic cancer	0.000131	0.000432	CcSEcCtD
Cefotetan—Nausea—Thiotepa—hematologic cancer	0.000131	0.000431	CcSEcCtD
Cefotetan—Anaphylactic shock—Betamethasone—hematologic cancer	0.000131	0.000429	CcSEcCtD
Cefotetan—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000131	0.000429	CcSEcCtD
Cefotetan—Diarrhoea—Mitoxantrone—hematologic cancer	0.000131	0.000429	CcSEcCtD
Cefotetan—Diarrhoea—Irinotecan—hematologic cancer	0.000131	0.000429	CcSEcCtD
Cefotetan—Vomiting—Carmustine—hematologic cancer	0.00013	0.000429	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—hematologic cancer	0.00013	0.000428	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etoposide—hematologic cancer	0.00013	0.000427	CcSEcCtD
Cefotetan—Rash—Carmustine—hematologic cancer	0.000129	0.000425	CcSEcCtD
Cefotetan—Dermatitis—Carmustine—hematologic cancer	0.000129	0.000425	CcSEcCtD
Cefotetan—Vomiting—Alitretinoin—hematologic cancer	0.000129	0.000425	CcSEcCtD
Cefotetan—Rash—Alitretinoin—hematologic cancer	0.000128	0.000421	CcSEcCtD
Cefotetan—Dermatitis—Alitretinoin—hematologic cancer	0.000128	0.000421	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000128	0.000421	CcSEcCtD
Cefotetan—Thrombocytopenia—Betamethasone—hematologic cancer	0.000128	0.00042	CcSEcCtD
Cefotetan—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000128	0.00042	CcSEcCtD
Cefotetan—Vomiting—Ifosfamide—hematologic cancer	0.000128	0.00042	CcSEcCtD
Cefotetan—Hypersensitivity—Cisplatin—hematologic cancer	0.000128	0.00042	CcSEcCtD
Cefotetan—Diarrhoea—Gemcitabine—hematologic cancer	0.000127	0.000418	CcSEcCtD
Cefotetan—Nausea—Thalidomide—hematologic cancer	0.000127	0.000417	CcSEcCtD
Cefotetan—Rash—Ifosfamide—hematologic cancer	0.000127	0.000416	CcSEcCtD
Cefotetan—Dermatitis—Ifosfamide—hematologic cancer	0.000127	0.000416	CcSEcCtD
Cefotetan—Erythema multiforme—Methotrexate—hematologic cancer	0.000126	0.000416	CcSEcCtD
Cefotetan—Urticaria—Etoposide—hematologic cancer	0.000126	0.000414	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—hematologic cancer	0.000126	0.000414	CcSEcCtD
Cefotetan—Abdominal pain—Etoposide—hematologic cancer	0.000125	0.000412	CcSEcCtD
Cefotetan—Body temperature increased—Etoposide—hematologic cancer	0.000125	0.000412	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—hematologic cancer	0.000125	0.000412	CcSEcCtD
Cefotetan—Vomiting—Vincristine—hematologic cancer	0.000125	0.000409	CcSEcCtD
Cefotetan—Urticaria—Prednisolone—hematologic cancer	0.000124	0.000409	CcSEcCtD
Cefotetan—Rash—Vincristine—hematologic cancer	0.000123	0.000406	CcSEcCtD
Cefotetan—Dermatitis—Vincristine—hematologic cancer	0.000123	0.000406	CcSEcCtD
Cefotetan—Nausea—Carmustine—hematologic cancer	0.000122	0.000401	CcSEcCtD
Cefotetan—Vomiting—Irinotecan—hematologic cancer	0.000121	0.000399	CcSEcCtD
Cefotetan—Vomiting—Mitoxantrone—hematologic cancer	0.000121	0.000399	CcSEcCtD
Cefotetan—Nausea—Alitretinoin—hematologic cancer	0.000121	0.000397	CcSEcCtD
Cefotetan—Convulsion—Prednisone—hematologic cancer	0.000121	0.000397	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—hematologic cancer	0.00012	0.000396	CcSEcCtD
Cefotetan—Rash—Mitoxantrone—hematologic cancer	0.00012	0.000395	CcSEcCtD
Cefotetan—Rash—Irinotecan—hematologic cancer	0.00012	0.000395	CcSEcCtD
Cefotetan—Dermatitis—Mitoxantrone—hematologic cancer	0.00012	0.000395	CcSEcCtD
Cefotetan—Dermatitis—Irinotecan—hematologic cancer	0.00012	0.000395	CcSEcCtD
Cefotetan—Nausea—Ifosfamide—hematologic cancer	0.000119	0.000392	CcSEcCtD
Cefotetan—Diarrhoea—Cisplatin—hematologic cancer	0.000118	0.00039	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—hematologic cancer	0.000118	0.000389	CcSEcCtD
Cefotetan—Vomiting—Gemcitabine—hematologic cancer	0.000118	0.000388	CcSEcCtD
Cefotetan—Discomfort—Prednisone—hematologic cancer	0.000117	0.000385	CcSEcCtD
Cefotetan—Rash—Gemcitabine—hematologic cancer	0.000117	0.000385	CcSEcCtD
Cefotetan—Dermatitis—Gemcitabine—hematologic cancer	0.000117	0.000385	CcSEcCtD
Cefotetan—Hypersensitivity—Etoposide—hematologic cancer	0.000117	0.000384	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—hematologic cancer	0.000116	0.000383	CcSEcCtD
Cefotetan—Nausea—Vincristine—hematologic cancer	0.000116	0.000383	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—hematologic cancer	0.000116	0.000381	CcSEcCtD
Cefotetan—Hypersensitivity—Prednisolone—hematologic cancer	0.000115	0.000379	CcSEcCtD
Cefotetan—Urticaria—Triamcinolone—hematologic cancer	0.000114	0.000376	CcSEcCtD
Cefotetan—Body temperature increased—Triamcinolone—hematologic cancer	0.000114	0.000374	CcSEcCtD
Cefotetan—Anaphylactic shock—Prednisone—hematologic cancer	0.000114	0.000374	CcSEcCtD
Cefotetan—Nausea—Mitoxantrone—hematologic cancer	0.000113	0.000373	CcSEcCtD
Cefotetan—Nausea—Irinotecan—hematologic cancer	0.000113	0.000373	CcSEcCtD
Cefotetan—Pruritus—Etoposide—hematologic cancer	0.000112	0.000369	CcSEcCtD
Cefotetan—Nausea—Gemcitabine—hematologic cancer	0.00011	0.000363	CcSEcCtD
Cefotetan—Vomiting—Cisplatin—hematologic cancer	0.00011	0.000362	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—hematologic cancer	0.00011	0.00036	CcSEcCtD
Cefotetan—Rash—Cisplatin—hematologic cancer	0.000109	0.000359	CcSEcCtD
Cefotetan—Dermatitis—Cisplatin—hematologic cancer	0.000109	0.000359	CcSEcCtD
Cefotetan—Diarrhoea—Etoposide—hematologic cancer	0.000109	0.000357	CcSEcCtD
Cefotetan—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000107	0.000351	CcSEcCtD
Cefotetan—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000107	0.000351	CcSEcCtD
Cefotetan—Hypersensitivity—Triamcinolone—hematologic cancer	0.000106	0.000349	CcSEcCtD
Cefotetan—Leukopenia—Methotrexate—hematologic cancer	0.000104	0.000343	CcSEcCtD
Cefotetan—Urticaria—Betamethasone—hematologic cancer	0.000104	0.000341	CcSEcCtD
Cefotetan—Urticaria—Dexamethasone—hematologic cancer	0.000104	0.000341	CcSEcCtD
Cefotetan—Abdominal pain—Betamethasone—hematologic cancer	0.000103	0.000339	CcSEcCtD
Cefotetan—Abdominal pain—Dexamethasone—hematologic cancer	0.000103	0.000339	CcSEcCtD
Cefotetan—Body temperature increased—Betamethasone—hematologic cancer	0.000103	0.000339	CcSEcCtD
Cefotetan—Body temperature increased—Dexamethasone—hematologic cancer	0.000103	0.000339	CcSEcCtD
Cefotetan—Nausea—Cisplatin—hematologic cancer	0.000103	0.000338	CcSEcCtD
Cefotetan—Pruritus—Triamcinolone—hematologic cancer	0.000102	0.000335	CcSEcCtD
Cefotetan—Convulsion—Methotrexate—hematologic cancer	0.000101	0.000332	CcSEcCtD
Cefotetan—Vomiting—Etoposide—hematologic cancer	0.000101	0.000332	CcSEcCtD
Cefotetan—Rash—Etoposide—hematologic cancer	0.0001	0.000329	CcSEcCtD
Cefotetan—Dermatitis—Etoposide—hematologic cancer	9.99e-05	0.000329	CcSEcCtD
Cefotetan—Rash—Prednisolone—hematologic cancer	9.87e-05	0.000324	CcSEcCtD
Cefotetan—Dermatitis—Prednisolone—hematologic cancer	9.86e-05	0.000324	CcSEcCtD
Cefotetan—Discomfort—Methotrexate—hematologic cancer	9.79e-05	0.000322	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—hematologic cancer	9.75e-05	0.000321	CcSEcCtD
Cefotetan—Anaphylactic shock—Methotrexate—hematologic cancer	9.5e-05	0.000312	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—hematologic cancer	9.44e-05	0.00031	CcSEcCtD
Cefotetan—Nausea—Etoposide—hematologic cancer	9.42e-05	0.00031	CcSEcCtD
Cefotetan—Thrombocytopenia—Methotrexate—hematologic cancer	9.3e-05	0.000306	CcSEcCtD
Cefotetan—Gastrointestinal pain—Prednisone—hematologic cancer	9.3e-05	0.000306	CcSEcCtD
Cefotetan—Nausea—Prednisolone—hematologic cancer	9.3e-05	0.000306	CcSEcCtD
Cefotetan—Pruritus—Betamethasone—hematologic cancer	9.24e-05	0.000304	CcSEcCtD
Cefotetan—Pruritus—Dexamethasone—hematologic cancer	9.24e-05	0.000304	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—hematologic cancer	9.17e-05	0.000301	CcSEcCtD
Cefotetan—Vomiting—Triamcinolone—hematologic cancer	9.15e-05	0.000301	CcSEcCtD
Cefotetan—Rash—Triamcinolone—hematologic cancer	9.07e-05	0.000298	CcSEcCtD
Cefotetan—Dermatitis—Triamcinolone—hematologic cancer	9.07e-05	0.000298	CcSEcCtD
Cefotetan—Urticaria—Prednisone—hematologic cancer	9.03e-05	0.000297	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—hematologic cancer	9.03e-05	0.000297	CcSEcCtD
Cefotetan—Abdominal pain—Prednisone—hematologic cancer	8.99e-05	0.000296	CcSEcCtD
Cefotetan—Body temperature increased—Prednisone—hematologic cancer	8.99e-05	0.000296	CcSEcCtD
Cefotetan—Diarrhoea—Betamethasone—hematologic cancer	8.93e-05	0.000294	CcSEcCtD
Cefotetan—Diarrhoea—Dexamethasone—hematologic cancer	8.93e-05	0.000294	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—hematologic cancer	8.89e-05	0.000292	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—hematologic cancer	8.74e-05	0.000287	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—hematologic cancer	8.71e-05	0.000286	CcSEcCtD
Cefotetan—Nausea—Triamcinolone—hematologic cancer	8.55e-05	0.000281	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—hematologic cancer	8.48e-05	0.000279	CcSEcCtD
Cefotetan—Hypersensitivity—Prednisone—hematologic cancer	8.38e-05	0.000275	CcSEcCtD
Cefotetan—Vomiting—Betamethasone—hematologic cancer	8.3e-05	0.000273	CcSEcCtD
Cefotetan—Vomiting—Dexamethasone—hematologic cancer	8.3e-05	0.000273	CcSEcCtD
Cefotetan—Rash—Dexamethasone—hematologic cancer	8.23e-05	0.000271	CcSEcCtD
Cefotetan—Rash—Betamethasone—hematologic cancer	8.23e-05	0.000271	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—hematologic cancer	8.23e-05	0.000271	CcSEcCtD
Cefotetan—Dermatitis—Betamethasone—hematologic cancer	8.23e-05	0.00027	CcSEcCtD
Cefotetan—Dermatitis—Dexamethasone—hematologic cancer	8.23e-05	0.00027	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—hematologic cancer	8.06e-05	0.000265	CcSEcCtD
Cefotetan—Pruritus—Prednisone—hematologic cancer	8.05e-05	0.000265	CcSEcCtD
Cefotetan—Diarrhoea—Prednisone—hematologic cancer	7.78e-05	0.000256	CcSEcCtD
Cefotetan—Gastrointestinal pain—Methotrexate—hematologic cancer	7.77e-05	0.000256	CcSEcCtD
Cefotetan—Nausea—Dexamethasone—hematologic cancer	7.76e-05	0.000255	CcSEcCtD
Cefotetan—Nausea—Betamethasone—hematologic cancer	7.76e-05	0.000255	CcSEcCtD
Cefotetan—Urticaria—Methotrexate—hematologic cancer	7.55e-05	0.000248	CcSEcCtD
Cefotetan—Body temperature increased—Methotrexate—hematologic cancer	7.51e-05	0.000247	CcSEcCtD
Cefotetan—Abdominal pain—Methotrexate—hematologic cancer	7.51e-05	0.000247	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—hematologic cancer	7.27e-05	0.000239	CcSEcCtD
Cefotetan—Vomiting—Prednisone—hematologic cancer	7.23e-05	0.000238	CcSEcCtD
Cefotetan—Rash—Prednisone—hematologic cancer	7.17e-05	0.000236	CcSEcCtD
Cefotetan—Dermatitis—Prednisone—hematologic cancer	7.16e-05	0.000236	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—hematologic cancer	7.07e-05	0.000232	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—hematologic cancer	7.03e-05	0.000231	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—hematologic cancer	7.03e-05	0.000231	CcSEcCtD
Cefotetan—Hypersensitivity—Methotrexate—hematologic cancer	7e-05	0.00023	CcSEcCtD
Cefotetan—Nausea—Prednisone—hematologic cancer	6.75e-05	0.000222	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.73e-05	0.000221	CcSEcCtD
Cefotetan—Pruritus—Methotrexate—hematologic cancer	6.72e-05	0.000221	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—hematologic cancer	6.55e-05	0.000215	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—hematologic cancer	6.54e-05	0.000215	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—hematologic cancer	6.51e-05	0.000214	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—hematologic cancer	6.51e-05	0.000214	CcSEcCtD
Cefotetan—Diarrhoea—Methotrexate—hematologic cancer	6.5e-05	0.000214	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—hematologic cancer	6.29e-05	0.000207	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—hematologic cancer	6.09e-05	0.0002	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—hematologic cancer	6.06e-05	0.000199	CcSEcCtD
Cefotetan—Vomiting—Methotrexate—hematologic cancer	6.04e-05	0.000199	CcSEcCtD
Cefotetan—Rash—Methotrexate—hematologic cancer	5.99e-05	0.000197	CcSEcCtD
Cefotetan—Dermatitis—Methotrexate—hematologic cancer	5.99e-05	0.000197	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—hematologic cancer	5.82e-05	0.000191	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—hematologic cancer	5.65e-05	0.000186	CcSEcCtD
Cefotetan—Nausea—Methotrexate—hematologic cancer	5.64e-05	0.000186	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—hematologic cancer	5.63e-05	0.000185	CcSEcCtD
Cefotetan—Rash—Epirubicin—hematologic cancer	5.61e-05	0.000184	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—hematologic cancer	5.6e-05	0.000184	CcSEcCtD
Cefotetan—Nausea—Epirubicin—hematologic cancer	5.28e-05	0.000174	CcSEcCtD
Cefotetan—ALB—Vitamin B12 Metabolism—CRP—hematologic cancer	5.24e-05	0.0057	CbGpPWpGaD
Cefotetan—Vomiting—Doxorubicin—hematologic cancer	5.23e-05	0.000172	CcSEcCtD
Cefotetan—Rash—Doxorubicin—hematologic cancer	5.19e-05	0.000171	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—hematologic cancer	5.18e-05	0.00017	CcSEcCtD
Cefotetan—ALB—Folate Metabolism—SOD2—hematologic cancer	5.09e-05	0.00554	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.96e-05	0.0054	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL4—hematologic cancer	4.93e-05	0.00537	CbGpPWpGaD
Cefotetan—Nausea—Doxorubicin—hematologic cancer	4.89e-05	0.000161	CcSEcCtD
Cefotetan—ALB—Hemostasis—CD2—hematologic cancer	4.85e-05	0.00528	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—ICAM1—hematologic cancer	4.82e-05	0.00524	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—PDGFA—hematologic cancer	4.8e-05	0.00522	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.74e-05	0.00516	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—GNA13—hematologic cancer	4.59e-05	0.005	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PDGFA—hematologic cancer	4.57e-05	0.00498	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—MTHFR—hematologic cancer	4.48e-05	0.00488	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	4.41e-05	0.0048	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—JAK3—hematologic cancer	4.38e-05	0.00477	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—HGF—hematologic cancer	4.35e-05	0.00473	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CD9—hematologic cancer	4.32e-05	0.0047	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—CCL2—hematologic cancer	4.31e-05	0.00469	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CRP—hematologic cancer	4.26e-05	0.00464	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—HGF—hematologic cancer	4.14e-05	0.00451	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—THPO—hematologic cancer	4.12e-05	0.00449	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD58—hematologic cancer	4.12e-05	0.00449	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IL3RA—hematologic cancer	4.09e-05	0.00445	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SOD2—hematologic cancer	4.04e-05	0.0044	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	4.04e-05	0.00439	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—hematologic cancer	3.95e-05	0.0043	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—ICAM1—hematologic cancer	3.92e-05	0.00427	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.84e-05	0.00418	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—PDGFB—hematologic cancer	3.74e-05	0.00407	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SRGN—hematologic cancer	3.67e-05	0.004	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IFNG—hematologic cancer	3.67e-05	0.00399	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.57e-05	0.00388	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—hematologic cancer	3.56e-05	0.00388	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MTHFR—hematologic cancer	3.56e-05	0.00387	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—CCL2—hematologic cancer	3.51e-05	0.00382	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MPL—hematologic cancer	3.5e-05	0.00381	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—RAC2—hematologic cancer	3.42e-05	0.00373	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CRP—hematologic cancer	3.39e-05	0.00369	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—FN1—hematologic cancer	3.37e-05	0.00367	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—S100A10—hematologic cancer	3.36e-05	0.00366	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL1B—hematologic cancer	3.27e-05	0.00356	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GATA2—hematologic cancer	3.23e-05	0.00352	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—FN1—hematologic cancer	3.21e-05	0.0035	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	3.14e-05	0.00341	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	3.11e-05	0.00339	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IFNG—hematologic cancer	2.98e-05	0.00325	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.96e-05	0.00322	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	2.96e-05	0.00322	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ATP1B1—hematologic cancer	2.94e-05	0.0032	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.91e-05	0.00317	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	2.87e-05	0.00312	CbGpPWpGaD
Cefotetan—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.85e-05	0.0031	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.84e-05	0.00309	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	2.79e-05	0.00303	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GATA1—hematologic cancer	2.78e-05	0.00303	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	2.77e-05	0.00301	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	2.73e-05	0.00297	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.7e-05	0.00294	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL1B—hematologic cancer	2.66e-05	0.00289	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL2—hematologic cancer	2.65e-05	0.00288	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ANXA2—hematologic cancer	2.55e-05	0.00277	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.54e-05	0.00277	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	2.45e-05	0.00267	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	2.41e-05	0.00263	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.41e-05	0.00262	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	2.37e-05	0.00258	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	2.37e-05	0.00258	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	2.37e-05	0.00258	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GNA13—hematologic cancer	2.37e-05	0.00258	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	2.37e-05	0.00257	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.32e-05	0.00252	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—JAK3—hematologic cancer	2.26e-05	0.00246	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGAX—hematologic cancer	2.26e-05	0.00246	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD9—hematologic cancer	2.23e-05	0.00242	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—F3—hematologic cancer	2.23e-05	0.00242	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.2e-05	0.0024	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.2e-05	0.0024	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.2e-05	0.0024	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SELL—hematologic cancer	2.17e-05	0.00236	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	2.13e-05	0.00232	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	2.13e-05	0.00232	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	2.11e-05	0.0023	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IL3RA—hematologic cancer	2.11e-05	0.0023	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.03e-05	0.00221	CbGpPWpGaD
Cefotetan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.99e-05	0.00216	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.98e-05	0.00216	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GMPS—hematologic cancer	1.97e-05	0.00214	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FTCD—hematologic cancer	1.97e-05	0.00214	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PHYH—hematologic cancer	1.97e-05	0.00214	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.95e-05	0.00212	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.93e-05	0.0021	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—hematologic cancer	1.93e-05	0.0021	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FGR—hematologic cancer	1.93e-05	0.0021	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—H3F3B—hematologic cancer	1.93e-05	0.0021	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.93e-05	0.0021	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.91e-05	0.00208	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.91e-05	0.00208	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGAL—hematologic cancer	1.86e-05	0.00202	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MYB—hematologic cancer	1.86e-05	0.00202	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.85e-05	0.00202	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.84e-05	0.002	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.84e-05	0.002	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.84e-05	0.002	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.83e-05	0.00199	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SMPD3—hematologic cancer	1.8e-05	0.00196	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.79e-05	0.00195	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.77e-05	0.00193	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RAC2—hematologic cancer	1.77e-05	0.00192	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.74e-05	0.0019	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.72e-05	0.00187	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TP53—hematologic cancer	1.7e-05	0.00185	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.69e-05	0.00184	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.68e-05	0.00182	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.66e-05	0.00181	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.63e-05	0.00178	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SH2B3—hematologic cancer	1.6e-05	0.00174	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.59e-05	0.00173	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ASNS—hematologic cancer	1.57e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Metabolism—DCK—hematologic cancer	1.57e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Metabolism—B3GAT1—hematologic cancer	1.57e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—hematologic cancer	1.56e-05	0.0017	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.54e-05	0.00168	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.54e-05	0.00167	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.53e-05	0.00167	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SPARC—hematologic cancer	1.53e-05	0.00166	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.5e-05	0.00164	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.5e-05	0.00163	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HDC—hematologic cancer	1.49e-05	0.00162	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—LCK—hematologic cancer	1.48e-05	0.00161	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.46e-05	0.00159	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.45e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—H3F3A—hematologic cancer	1.45e-05	0.00158	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GATA3—hematologic cancer	1.43e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.43e-05	0.00156	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HSPA5—hematologic cancer	1.43e-05	0.00155	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.42e-05	0.00155	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCZ—hematologic cancer	1.41e-05	0.00153	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.39e-05	0.00151	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CDA—hematologic cancer	1.36e-05	0.00148	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HDAC2—hematologic cancer	1.31e-05	0.00143	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PC—hematologic cancer	1.31e-05	0.00143	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CD44—hematologic cancer	1.3e-05	0.00141	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ITGA4—hematologic cancer	1.3e-05	0.00141	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GBA—hematologic cancer	1.27e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC35B2—hematologic cancer	1.27e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.27e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IL3—hematologic cancer	1.26e-05	0.00138	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.26e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IFNA1—hematologic cancer	1.26e-05	0.00137	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PTPN1—hematologic cancer	1.24e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.24e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RASGRP1—hematologic cancer	1.22e-05	0.00133	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SYK—hematologic cancer	1.22e-05	0.00133	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.19e-05	0.00129	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IFNA2—hematologic cancer	1.17e-05	0.00127	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTAP—hematologic cancer	1.16e-05	0.00126	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.16e-05	0.00126	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—GRB2—hematologic cancer	1.1e-05	0.0012	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PDGFA—hematologic cancer	1.1e-05	0.00119	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	1.1e-05	0.00119	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.06e-05	0.00116	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ABL1—hematologic cancer	1.06e-05	0.00115	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FHL2—hematologic cancer	1.03e-05	0.00112	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AGRN—hematologic cancer	1.01e-05	0.0011	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	1.01e-05	0.0011	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HGF—hematologic cancer	9.94e-06	0.00108	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CSF2—hematologic cancer	9.83e-06	0.00107	CbGpPWpGaD
Cefotetan—ALB—Metabolism—IDH2—hematologic cancer	9.6e-06	0.00104	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HMMR—hematologic cancer	9.6e-06	0.00104	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—JAK1—hematologic cancer	9.49e-06	0.00103	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PRKCG—hematologic cancer	9.49e-06	0.00103	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.05e-06	0.000985	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ARNTL—hematologic cancer	9.02e-06	0.000982	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.87e-06	0.000965	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IL2RA—hematologic cancer	8.86e-06	0.000964	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	8.79e-06	0.000957	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ACP5—hematologic cancer	8.78e-06	0.000955	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CA9—hematologic cancer	8.78e-06	0.000955	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOR2—hematologic cancer	8.66e-06	0.000943	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	8.57e-06	0.000932	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PDGFB—hematologic cancer	8.55e-06	0.000931	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CDK2—hematologic cancer	8.3e-06	0.000903	CbGpPWpGaD
Cefotetan—ALB—Metabolism—IDH1—hematologic cancer	8.25e-06	0.000898	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCC3—hematologic cancer	8.16e-06	0.000888	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TXN—hematologic cancer	8.16e-06	0.000888	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTO1—hematologic cancer	8.16e-06	0.000888	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	8.1e-06	0.000882	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SPHK1—hematologic cancer	7.99e-06	0.000869	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK14—hematologic cancer	7.96e-06	0.000866	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	7.86e-06	0.000855	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FN1—hematologic cancer	7.71e-06	0.000839	CbGpPWpGaD
Cefotetan—ALB—Metabolism—UGT1A1—hematologic cancer	7.67e-06	0.000835	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SLC22A1—hematologic cancer	7.46e-06	0.000812	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CRABP1—hematologic cancer	7.46e-06	0.000812	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CG—hematologic cancer	7.38e-06	0.000803	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ALOX5—hematologic cancer	7.27e-06	0.000792	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PTPN11—hematologic cancer	7.25e-06	0.000789	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NUP98—hematologic cancer	7.05e-06	0.000767	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CREBBP—hematologic cancer	6.84e-06	0.000745	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOA3—hematologic cancer	6.84e-06	0.000744	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADCY7—hematologic cancer	6.84e-06	0.000744	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NUP214—hematologic cancer	6.79e-06	0.000739	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.72e-06	0.000731	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.69e-06	0.000728	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCG2—hematologic cancer	6.65e-06	0.000724	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTR—hematologic cancer	6.65e-06	0.000724	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ENO2—hematologic cancer	6.52e-06	0.00071	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CD—hematologic cancer	6.49e-06	0.000706	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTT1—hematologic cancer	6.33e-06	0.000689	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.23e-06	0.000678	CbGpPWpGaD
Cefotetan—ALB—Metabolism—SDC1—hematologic cancer	6.19e-06	0.000673	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3R1—hematologic cancer	6.13e-06	0.000667	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—JAK2—hematologic cancer	5.96e-06	0.000648	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.93e-06	0.000645	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.91e-06	0.000643	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CB—hematologic cancer	5.66e-06	0.000616	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.58e-06	0.000607	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.47e-06	0.000595	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CD44—hematologic cancer	5.26e-06	0.000572	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NQO1—hematologic cancer	5.26e-06	0.000572	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IL2—hematologic cancer	5.2e-06	0.000565	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.15e-06	0.00056	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYCS—hematologic cancer	4.98e-06	0.000542	CbGpPWpGaD
Cefotetan—ALB—Metabolism—HSP90AA1—hematologic cancer	4.94e-06	0.000538	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—EP300—hematologic cancer	4.66e-06	0.000507	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—SRC—hematologic cancer	4.53e-06	0.000493	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.45e-06	0.000484	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VEGFA—hematologic cancer	4.42e-06	0.00048	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTP1—hematologic cancer	4.39e-06	0.000477	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—NRAS—hematologic cancer	4.36e-06	0.000475	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.24e-06	0.000462	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MAPK3—hematologic cancer	4.18e-06	0.000454	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ABCB1—hematologic cancer	4.15e-06	0.000452	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—hematologic cancer	4.05e-06	0.000441	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GSTM1—hematologic cancer	4.03e-06	0.000439	CbGpPWpGaD
Cefotetan—ALB—Metabolism—NCOR1—hematologic cancer	4.03e-06	0.000439	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—KRAS—hematologic cancer	3.75e-06	0.000408	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—hematologic cancer	3.56e-06	0.000388	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PIK3CA—hematologic cancer	3.45e-06	0.000375	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TP53—hematologic cancer	3.34e-06	0.000363	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—HRAS—hematologic cancer	3.19e-06	0.000347	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.14e-06	0.000342	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CG—hematologic cancer	2.99e-06	0.000326	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—AKT1—hematologic cancer	2.82e-06	0.000307	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CREBBP—hematologic cancer	2.78e-06	0.000302	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CD—hematologic cancer	2.63e-06	0.000286	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3R1—hematologic cancer	2.48e-06	0.00027	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CB—hematologic cancer	2.29e-06	0.00025	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PTEN—hematologic cancer	1.98e-06	0.000216	CbGpPWpGaD
Cefotetan—ALB—Metabolism—EP300—hematologic cancer	1.89e-06	0.000206	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PIK3CA—hematologic cancer	1.4e-06	0.000152	CbGpPWpGaD
Cefotetan—ALB—Metabolism—AKT1—hematologic cancer	1.14e-06	0.000124	CbGpPWpGaD
